Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 697 to 705 of 705 entries
Sorted by: Best Match Show Resources per page
Robot-Supported Collaborative Learning (RSCL): Social Robots as Teaching Assistants for Higher Education Small Group Facilitation.

Frontiers in robotics and AI

Rosenberg-Kima RB, Koren Y, Gordon G.
PMID: 33501163
Front Robot AI. 2020 Jan 10;6:148. doi: 10.3389/frobt.2019.00148. eCollection 2019.

Acknowledging the benefits of active learning and the importance of collaboration skills, the higher education system has started to transform toward utilization of group activities into lecture hall culture. In this study, a novel interaction has been introduced, wherein...

Cite
Rosenberg-Kima RB, Koren Y, Gordon G. Robot-Supported Collaborative Learning (RSCL): Social Robots as Teaching Assistants for Higher Education Small Group Facilitation. Front Robot AI. 2020;6:148doi: 10.3389/frobt.2019.00148.
Rosenberg-Kima, R. B., Koren, Y., & Gordon, G. (2019). Robot-Supported Collaborative Learning (RSCL): Social Robots as Teaching Assistants for Higher Education Small Group Facilitation. Frontiers in robotics and AI, 6148. https://doi.org/10.3389/frobt.2019.00148
Rosenberg-Kima, Rinat B, et al. "Robot-Supported Collaborative Learning (RSCL): Social Robots as Teaching Assistants for Higher Education Small Group Facilitation." Frontiers in robotics and AI vol. 6 (2019): 148. doi: https://doi.org/10.3389/frobt.2019.00148
Rosenberg-Kima RB, Koren Y, Gordon G. Robot-Supported Collaborative Learning (RSCL): Social Robots as Teaching Assistants for Higher Education Small Group Facilitation. Front Robot AI. 2020 Jan 10;6:148. doi: 10.3389/frobt.2019.00148. eCollection 2019. PMID: 33501163; PMCID: PMC7805738.
Copy Download .nbib Format: NLM
Forward Chemical Genetic Screen for Oxygen-Dependent Cytotoxins Uncovers New Covalent Fragments that Target GPX4.

Chembiochem : a European journal of chemical biology

Cordon MB, Jacobsen KM, Nielsen CS, Hjerrild P, Poulsen TB.
PMID: 34252249
Chembiochem. 2021 Jul 12; doi: 10.1002/cbic.202100253. Epub 2021 Jul 12.

The identification of growth inhibitory compounds with the ability to selectively target the cellular oxygenation state may be of therapeutic interest. Here, a phenotypic screen of a covalent fragment library revealed diverse compounds containing propiolamide warheads with selective toxicity...

Cite
Cordon MB, Jacobsen KM, Nielsen CS, et al. Forward Chemical Genetic Screen for Oxygen-Dependent Cytotoxins Uncovers New Covalent Fragments that Target GPX4. Chembiochem. 2021;doi: 10.1002/cbic.202100253.
Cordon, M. B., Jacobsen, K. M., Nielsen, C. S., Hjerrild, P., & Poulsen, T. B. (2021). Forward Chemical Genetic Screen for Oxygen-Dependent Cytotoxins Uncovers New Covalent Fragments that Target GPX4. Chembiochem : a European journal of chemical biology, . https://doi.org/10.1002/cbic.202100253
Cordon, Marie B, et al. "Forward Chemical Genetic Screen for Oxygen-Dependent Cytotoxins Uncovers New Covalent Fragments that Target GPX4." Chembiochem : a European journal of chemical biology vol. (2021). doi: https://doi.org/10.1002/cbic.202100253
Cordon MB, Jacobsen KM, Nielsen CS, Hjerrild P, Poulsen TB. Forward Chemical Genetic Screen for Oxygen-Dependent Cytotoxins Uncovers New Covalent Fragments that Target GPX4. Chembiochem. 2021 Jul 12; doi: 10.1002/cbic.202100253. Epub 2021 Jul 12. PMID: 34252249.
Copy Download .nbib Format: NLM
Deucravacitinib in Moderate to Severe Psoriasis: Clinical and Quality-of-Life Outcomes in a Phase 2 Trial.

Dermatology and therapy

Thaçi D, Strober B, Gordon KB, Foley P, Gooderham M, Morita A, Papp KA, Puig L, Menter MA, Colombo MJ, Elbez Y, Kisa RM, Ye J, Napoli AA, Wei L, Banerjee S, Merola JF, Gottlieb AB.
PMID: 35025062
Dermatol Ther (Heidelb). 2022 Jan 13; doi: 10.1007/s13555-021-00649-y. Epub 2022 Jan 13.

INTRODUCTION: Deucravacitinib is an oral, selective tyrosine kinase 2 inhibitor that demonstrated therapeutic benefit in a Phase 2 clinical trial of adults with moderate to severe plaque psoriasis. This analysis was designed to evaluate the effect of deucravacitinib on...

Cite
Thaçi D, Strober B, Gordon KB, et al. Deucravacitinib in Moderate to Severe Psoriasis: Clinical and Quality-of-Life Outcomes in a Phase 2 Trial. Dermatol Ther (Heidelb). 2022;doi: 10.1007/s13555-021-00649-y.
Thaçi, D., Strober, B., Gordon, K. B., Foley, P., Gooderham, M., Morita, A., Papp, K. A., Puig, L., Menter, M. A., Colombo, M. J., Elbez, Y., Kisa, R. M., Ye, J., Napoli, A. A., Wei, L., Banerjee, S., Merola, J. F., & Gottlieb, A. B. (2022). Deucravacitinib in Moderate to Severe Psoriasis: Clinical and Quality-of-Life Outcomes in a Phase 2 Trial. Dermatology and therapy, . https://doi.org/10.1007/s13555-021-00649-y
Thaçi, Diamant, et al. "Deucravacitinib in Moderate to Severe Psoriasis: Clinical and Quality-of-Life Outcomes in a Phase 2 Trial." Dermatology and therapy vol. (2022). doi: https://doi.org/10.1007/s13555-021-00649-y
Thaçi D, Strober B, Gordon KB, Foley P, Gooderham M, Morita A, Papp KA, Puig L, Menter MA, Colombo MJ, Elbez Y, Kisa RM, Ye J, Napoli AA, Wei L, Banerjee S, Merola JF, Gottlieb AB. Deucravacitinib in Moderate to Severe Psoriasis: Clinical and Quality-of-Life Outcomes in a Phase 2 Trial. Dermatol Ther (Heidelb). 2022 Jan 13; doi: 10.1007/s13555-021-00649-y. Epub 2022 Jan 13. PMID: 35025062.
Copy Download .nbib Format: NLM
Transportation Issues among Patients Receiving Intravitreal Injections at a Retinal Specialist Clinic (BURDEN Study).

Ophthalmology. Retina

Card KR, Gordon GM, Carron R, Winthrop M, Bagheri N, Pieramici DJ.
PMID: 33691181
Ophthalmol Retina. 2021 Oct;5(10):1052-1053. doi: 10.1016/j.oret.2021.03.004. Epub 2021 Mar 07.

No abstract available.

Cite
Card KR, Gordon GM, Carron R, et al. Transportation Issues among Patients Receiving Intravitreal Injections at a Retinal Specialist Clinic (BURDEN Study). Ophthalmol Retina. 2021;5(10):1052-1053doi: 10.1016/j.oret.2021.03.004.
Card, K. R., Gordon, G. M., Carron, R., Winthrop, M., Bagheri, N., & Pieramici, D. J. (2021). Transportation Issues among Patients Receiving Intravitreal Injections at a Retinal Specialist Clinic (BURDEN Study). Ophthalmology. Retina, 5(10), 1052-1053. https://doi.org/10.1016/j.oret.2021.03.004
Card, Kevin R, et al. "Transportation Issues among Patients Receiving Intravitreal Injections at a Retinal Specialist Clinic (BURDEN Study)." Ophthalmology. Retina vol. 5,10 (2021): 1052-1053. doi: https://doi.org/10.1016/j.oret.2021.03.004
Card KR, Gordon GM, Carron R, Winthrop M, Bagheri N, Pieramici DJ. Transportation Issues among Patients Receiving Intravitreal Injections at a Retinal Specialist Clinic (BURDEN Study). Ophthalmol Retina. 2021 Oct;5(10):1052-1053. doi: 10.1016/j.oret.2021.03.004. Epub 2021 Mar 07. PMID: 33691181.
Copy Download .nbib Format: NLM
Tightly coupled inhibitory and excitatory functional networks in the developing primary visual cortex.

eLife

Mulholland HN, Hein B, Kaschube M, Smith GB.
PMID: 34878404
Elife. 2021 Dec 08;10. doi: 10.7554/eLife.72456.

Intracortical inhibition plays a critical role in shaping activity patterns in the mature cortex. However, little is known about the structure of inhibition in early development prior to the onset of sensory experience, a time when spontaneous activity exhibits...

Cite
Mulholland HN, Hein B, Kaschube M, et al. Tightly coupled inhibitory and excitatory functional networks in the developing primary visual cortex. Elife. 2021;10doi: 10.7554/eLife.72456.
Mulholland, H. N., Hein, B., Kaschube, M., & Smith, G. B. (2021). Tightly coupled inhibitory and excitatory functional networks in the developing primary visual cortex. eLife, 10. https://doi.org/10.7554/eLife.72456
Mulholland, Haleigh N, et al. "Tightly coupled inhibitory and excitatory functional networks in the developing primary visual cortex." eLife vol. 10 (2021). doi: https://doi.org/10.7554/eLife.72456
Mulholland HN, Hein B, Kaschube M, Smith GB. Tightly coupled inhibitory and excitatory functional networks in the developing primary visual cortex. Elife. 2021 Dec 08;10. doi: 10.7554/eLife.72456. PMID: 34878404; PMCID: PMC8654369.
Copy Download .nbib Format: NLM
Direct growth of carbon nanotubes onto titanium dioxide nanoparticles.

Journal of nanoscience and nanotechnology

Dechakiatkrai C, Chen J, Lynam C, Wetchakul N, Phanichphant S, Wallace GG.
PMID: 19441430
J Nanosci Nanotechnol. 2009 Feb;9(2):955-9. doi: 10.1166/jnn.2009.c062.

Multi-wall carbon nanotubes (MWNTs) were successfully deposited on a TiO2 nanoparticle film via thermal chemical vapour deposition (CVD) using iron(III) as the catalyst, which was loaded into the titanium isopropoxide precursor solution. The properties of the TiO2/MWNTs nanocomposite was...

Cite
Dechakiatkrai C, Chen J, Lynam C, et al. Direct growth of carbon nanotubes onto titanium dioxide nanoparticles. J Nanosci Nanotechnol. 2009;9(2):955-9doi: 10.1166/jnn.2009.c062.
Dechakiatkrai, C., Chen, J., Lynam, C., Wetchakul, N., Phanichphant, S., & Wallace, G. G. (2009). Direct growth of carbon nanotubes onto titanium dioxide nanoparticles. Journal of nanoscience and nanotechnology, 9(2), 955-9. https://doi.org/10.1166/jnn.2009.c062
Dechakiatkrai, Chonlada, et al. "Direct growth of carbon nanotubes onto titanium dioxide nanoparticles." Journal of nanoscience and nanotechnology vol. 9,2 (2009): 955-9. doi: https://doi.org/10.1166/jnn.2009.c062
Dechakiatkrai C, Chen J, Lynam C, Wetchakul N, Phanichphant S, Wallace GG. Direct growth of carbon nanotubes onto titanium dioxide nanoparticles. J Nanosci Nanotechnol. 2009 Feb;9(2):955-9. doi: 10.1166/jnn.2009.c062. PMID: 19441430.
Copy Download .nbib Format: NLM
Phase Ib Dose Expansion and Translational Analyses of Olaparib in Combination with Capivasertib in Recurrent Endometrial, Triple-Negative Breast, and Ovarian Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research

Westin SN, Labrie M, Litton JK, Blucher A, Fang Y, Vellano CP, Marszalek JR, Feng N, Ma X, Creason A, Fellman B, Yuan Y, Lee S, Kim TB, Liu J, Chelariu-Raicu A, Chen TH, Kabil N, Soliman PT, Frumovitz M, Schmeler KM, Jazaeri A, Lu KH, Murthy R, Meyer LA, Sun CC, Sood AK, Coleman RL, Mills GB.
PMID: 34518313
Clin Cancer Res. 2021 Dec 01;27(23):6354-6365. doi: 10.1158/1078-0432.CCR-21-1656. Epub 2021 Sep 13.

PURPOSE: On the basis of strong preclinical rationale, we sought to confirm recommended phase II dose (RP2D) for olaparib, a PARP inhibitor, combined with the AKT inhibitor capivasertib and assess molecular markers of response and resistance.PATIENTS AND METHODS: We...

Cite
Westin SN, Labrie M, Litton JK, et al. Phase Ib Dose Expansion and Translational Analyses of Olaparib in Combination with Capivasertib in Recurrent Endometrial, Triple-Negative Breast, and Ovarian Cancer. Clin Cancer Res. 2021;27(23):6354-6365doi: 10.1158/1078-0432.CCR-21-1656.
Westin, S. N., Labrie, M., Litton, J. K., Blucher, A., Fang, Y., Vellano, C. P., Marszalek, J. R., Feng, N., Ma, X., Creason, A., Fellman, B., Yuan, Y., Lee, S., Kim, T. B., Liu, J., Chelariu-Raicu, A., Chen, T. H., Kabil, N., Soliman, P. T., Frumovitz, M., Schmeler, K. M., Jazaeri, A., Lu, K. H., Murthy, R., Meyer, L. A., Sun, C. C., Sood, A. K., Coleman, R. L., & Mills, G. B. (2021). Phase Ib Dose Expansion and Translational Analyses of Olaparib in Combination with Capivasertib in Recurrent Endometrial, Triple-Negative Breast, and Ovarian Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 27(23), 6354-6365. https://doi.org/10.1158/1078-0432.CCR-21-1656
Westin, Shannon N, et al. "Phase Ib Dose Expansion and Translational Analyses of Olaparib in Combination with Capivasertib in Recurrent Endometrial, Triple-Negative Breast, and Ovarian Cancer." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 27,23 (2021): 6354-6365. doi: https://doi.org/10.1158/1078-0432.CCR-21-1656
Westin SN, Labrie M, Litton JK, Blucher A, Fang Y, Vellano CP, Marszalek JR, Feng N, Ma X, Creason A, Fellman B, Yuan Y, Lee S, Kim TB, Liu J, Chelariu-Raicu A, Chen TH, Kabil N, Soliman PT, Frumovitz M, Schmeler KM, Jazaeri A, Lu KH, Murthy R, Meyer LA, Sun CC, Sood AK, Coleman RL, Mills GB. Phase Ib Dose Expansion and Translational Analyses of Olaparib in Combination with Capivasertib in Recurrent Endometrial, Triple-Negative Breast, and Ovarian Cancer. Clin Cancer Res. 2021 Dec 01;27(23):6354-6365. doi: 10.1158/1078-0432.CCR-21-1656. Epub 2021 Sep 13. PMID: 34518313; PMCID: PMC8639651.
Copy Download .nbib Format: NLM
Proton-Coupled Electron-Transfer Reactivity Controls Iron versus Sulfur Oxidation in Nonheme Iron-Thiolate Complexes.

Inorganic chemistry

Gordon JB, McGale JP, Siegler MA, Goldberg DP.
PMID: 33872005
Inorg Chem. 2021 May 03;60(9):6255-6265. doi: 10.1021/acs.inorgchem.0c03779. Epub 2021 Apr 19.

Reaction of the five-coordinate Fe

Cite
Gordon JB, McGale JP, Siegler MA, et al. Proton-Coupled Electron-Transfer Reactivity Controls Iron versus Sulfur Oxidation in Nonheme Iron-Thiolate Complexes. Inorg Chem. 2021;60(9):6255-6265doi: 10.1021/acs.inorgchem.0c03779.
Gordon, J. B., McGale, J. P., Siegler, M. A., & Goldberg, D. P. (2021). Proton-Coupled Electron-Transfer Reactivity Controls Iron versus Sulfur Oxidation in Nonheme Iron-Thiolate Complexes. Inorganic chemistry, 60(9), 6255-6265. https://doi.org/10.1021/acs.inorgchem.0c03779
Gordon, Jesse B, et al. "Proton-Coupled Electron-Transfer Reactivity Controls Iron versus Sulfur Oxidation in Nonheme Iron-Thiolate Complexes." Inorganic chemistry vol. 60,9 (2021): 6255-6265. doi: https://doi.org/10.1021/acs.inorgchem.0c03779
Gordon JB, McGale JP, Siegler MA, Goldberg DP. Proton-Coupled Electron-Transfer Reactivity Controls Iron versus Sulfur Oxidation in Nonheme Iron-Thiolate Complexes. Inorg Chem. 2021 May 03;60(9):6255-6265. doi: 10.1021/acs.inorgchem.0c03779. Epub 2021 Apr 19. PMID: 33872005; PMCID: PMC8139613.
Copy Download .nbib Format: NLM
Genetic alterations and expression characteristics of ARID1A impact tumor immune contexture and survival in early-onset gastric cancer.

American journal of cancer research

Zou J, Qin W, Yang L, Wang L, Wang Y, Shen J, Xiong W, Yu S, Song S, Ajani JA, Lin SY, Mills GB, Yuan X, Chen J, Peng G.
PMID: 33294279
Am J Cancer Res. 2020 Nov 01;10(11):3947-3972. eCollection 2020.

The AT-rich Interactive Domain 1A (ARID1A) is one of the most frequently mutated genes in gastric cancer. Here, we found that genetic variants in noncoding regions of ARID1A associated with altered protein levels by target sequencing. Notably, tumors with...

Cite
Zou J, Qin W, Yang L, et al. Genetic alterations and expression characteristics of ARID1A impact tumor immune contexture and survival in early-onset gastric cancer. Am J Cancer Res. 2020;10(11):3947-3972
Zou, J., Qin, W., Yang, L., Wang, L., Wang, Y., Shen, J., Xiong, W., Yu, S., Song, S., Ajani, J. A., Lin, S. Y., Mills, G. B., Yuan, X., Chen, J., & Peng, G. (2020). Genetic alterations and expression characteristics of ARID1A impact tumor immune contexture and survival in early-onset gastric cancer. American journal of cancer research, 10(11), 3947-3972.
Zou, Jun, et al. "Genetic alterations and expression characteristics of ARID1A impact tumor immune contexture and survival in early-onset gastric cancer." American journal of cancer research vol. 10,11 (2020): 3947-3972.
Zou J, Qin W, Yang L, Wang L, Wang Y, Shen J, Xiong W, Yu S, Song S, Ajani JA, Lin SY, Mills GB, Yuan X, Chen J, Peng G. Genetic alterations and expression characteristics of ARID1A impact tumor immune contexture and survival in early-onset gastric cancer. Am J Cancer Res. 2020 Nov 01;10(11):3947-3972. eCollection 2020. PMID: 33294279; PMCID: PMC7716160.
Copy Download .nbib Format: NLM
Showing 697 to 705 of 705 entries